| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| E793267 | 1446502-11-9 | Enasidenib (AG-221), 10mM in DMSO Enasidenib (AG-221), 10mM in DMSO |
C19H17F6N7O | |
| E872863 | 1446502-11-9 | Enasidenib (AG-221), 99% Enasidenib (AG-221), 99% |
C19H17F6N7O | |
| E881630 | 1650550-25-6 | Enasidenib mesylate, ≥99% Enasidenib mesylate, ≥99% |
C20H21F6N7O4S | |
| E884680 | 107361-33-1 | Enazadrem , ≥97% Enazadrem , ≥97% |
C18H25N3O | |
| E878496 | 550999-74-1 | Encenicline hydrochloride, ≥98% Encenicline hydrochloride, ≥98% |
C16H18Cl2N2OS | |
| E872422 | 1269440-17-6 | Encorafenib (LGX818), 99% Encorafenib (LGX818), 99% |
C22H27ClFN7O4S | |
| E883454 | 1276124-00-5 | Endomorphin 2 TFA , 98% Endomorphin 2 TFA , 98% |
C34H38F3N5O7 | |
| E879911 | 265646-85-3 | Endovion, 99% Endovion, 99% |
C16H9BrF6N6O | |
| E884074 | 1197194-61-8 | Endoxifen E-isomer hydrochloride, ≥98% Endoxifen E-isomer hydrochloride, ≥98% |
C25H28ClNO2 | |
| E879967 | 259525-01-4 | Enecadin , 98% Enecadin , 98% |
C21H28FN3O | |
| E880498 | 211813-86-4 | Eniporide hydrochloride, ≥99% Eniporide hydrochloride, ≥99% |
C14H17ClN4O3S | |
| E794799 | 934353-76-1 | ENMD-2076, 10mM in DMSO ENMD-2076, 10mM in DMSO |
C21H25N7 | |
| E861088 | 934353-76-1 | ENMD-2076, >98% ENMD2076, >98% |
C21H25N7 | |
| E795349 | 1291074-87-7 | ENMD-2076 L-(+)-Tartaric acid, 10mM in DMSO ENMD-2076 L-(+)-Tartaric acid, 10mM in DMSO |
C25H31N7O6 | |
| E872591 | 1291074-87-7 | ENMD-2076 L-(+)-Tartaric acid, 99% ENMD-2076 L-(+)-Tartaric acid, 99% |
C25H31N7O6 | |
| E884554 | 11029-12-2 | Enocyanin , 98% Enocyanin , 98% |
||
| E872994 | 679809-58-6 | Enoxaparin sodium, BR Enoxaparin sodium, BR |
||
| E766540 | 2378640-92-5 | ENPP1 Inhibitor C, 99% ENPP1 Inhibitor C, 99% |
C15H18N6 | |
| E872264 | 1370651-20-9 | Ensartinib (X-396), 98% Ensartinib (X-396), 98% |
C26H27Cl2FN6O3 | |
| T934070 | 1329568-92-4 | ent-Tadalafil-D3, ≥98% ent-Tadalafil-d3, ≥98% |
C22H16D3N3O4 |